Clarasight and SQUAKE Partner to Enable Data-Driven Carbon Reduction for Business Travel
Strategic Partnership Empowers Businesses to Accurately Plan and Reduce Travel Emissions BERLIN & NEW YORK–(BUSINESS WIRE)–Clarasight, the leading... Read more.
Riverbed Unveils Most Advanced AI-Powered Platform to Optimize Digital Experiences, and New Solutions for Mobile, Cloud, AIOps
New open Platform optimizes digital experiences by leveraging full-fidelity data and AI to automate prevention, identification, and resolution of IT issues New observability... Read more.
Manhattan Unified Supply Chain Powers Schneider Electric’s Global Distribution and Transportation Transformation
LONDON–(BUSINESS WIRE)–Manhattan Associates Inc. (NASDAQ: MANH) today announced that leading global energy management and industrial automation organisation,... Read more.
QVC Signs Multi-Year Contract Extensions with SES in Germany and the UK
Worldwide leader in video commerce extends long-standing partnership to continue broadcasting multiple HD and SD channels from SES’s prime 19.2 degrees East and... Read more.
Nidec Announces the Status of Own Share Repurchase
(Repurchase of own shares, pursuant to the Company’s Articles of Incorporation based on the provisions of Item 1 of Article 459 (1) of the Companies Act of Japan)... Read more.
Nidec Announces the Status of Own Share Repurchase
(Repurchase of own shares, pursuant to the Company’s Articles of Incorporation based on the provisions of Item 1 of Article 459 (1) of the Companies Act of Japan)... Read more.
Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 29, 2024
MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes... Read more.
First Surgeries Using Stryker’s Infinity With Adaptis and Everlast Successfully Completed in Europe
Infinity with Adaptis and Everlast Total Ankle System, featuring Prophecy Surgical Planning, is designed to deliver efficient and accurate implementation AMSTERDAM–(BUSINESS... Read more.
Faraday Future Issues Statement on Recent Social Media Post
LOS ANGELES–(BUSINESS WIRE)–Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global... Read more.
Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)
A breakthrough approach and supporting data using epigenome editing technology for the treatment of a type of muscular dystrophy, LAMA2-congenital muscular dystrophy... Read more.